Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CVI-HBV-002 / CHA Vaccine Institute
NCT04289987: A Study to Evaluate the Efficacy and Safety of Therapeutic Hepatitis B Vaccine	Completed	2	134	RoW	CVI-HBV-002, Normal Saline(placebo)	CHA Vaccine Institute Co., Ltd.	Hepatitis B, Chronic	12/23	12/23
CVI-HBV-002, NCT06147895: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Prophylactic Hepatitis B Vaccine	Completed	1	30	RoW	CVI-HBV-002	CHA Vaccine Institute Co., Ltd.	Vaccine-Preventable Diseases, Hepatitis B	09/23	09/23
CVI-HBV-001 / CHA Vaccine Institute
No trials found
L-pampo / CHA Vaccine Institute
No trials found